Neimeth Explains Agenda For N5b Fresh Capital

Neimeth Explains Agenda For N5b Fresh Capital

Shareholders of  Neimeth International Pharmaceuticals PLC have approved the plan of the Board to raise the sum of N5 billion through a hybrid offering of Rights to existing shareholders and private placement. The money will be used to finance major...
read more